JMI Syringes & Medical Devices Limited announcements
208 Dhaka Stock Exchange announcements for JMI Syringes & Medical Devices Limited (JMISMDL) since 2013: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2021 (15).
- The Company has informed that the Board of Directors has approved investment amounting U$ 6,14,984.00 (USD Six lac fourt
The Company has informed that the Board of Directors has approved investment amounting U$ 6,14,984.00 (USD Six lac fourteen thousand nine hundred eighty four) only for purchasing of machineries and related expenses to meet-up the market demand in the Country as well as to meet the global demand to increase existing production capacity of 0.5 ml Auto Disable (AD) Syringes. The new investment will be funded by using organically generated cash flow from the business. (cont.)
- Purchase of machineries
(Continuation news of JMISMDL): After implementation of the aforesaid expansion project, yearly production capacity of only 0.5ml Auto Disable (AD) Syringes will be increased by 33% approximately. (end)
The first part of this announcement is missing from the archive. - Alpha Credit Rating Limited (AlphaRating) has rated the Company as \"A+\" in the long term and \"ST-1\" in the short ter
Alpha Credit Rating Limited (AlphaRating) has rated the Company as \"A+\" in the long term and \"ST-1\" in the short term along with a stable outlook based on audited financial statements of the Company up to June 30, 2021 and relevant qualitative information till December 01, 2021.
- Resumption after record date
Trading of the shares of the Company will resume on 21.11.2021 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 18.11.2021.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.86 for July-September 2021 as against Tk. 0.80 for July-September 2020; NOCFPS was Tk. 0.80 for July-September 2021 as against Tk. 1.73 for July-September 2020. NAV per share was Tk. 123.55 as on September 30, 2021 and Tk. 122.47 as on September 30, 2020.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 16.11.2021 to 17.11.2021. Trading of the shares of the Company will remain suspended on record date i.e., 18.11.2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.
- Dividend Declaration
The Board of Directors has recommended 30% cash dividend for the year ended on June 30, 2021. Date of AGM: 29.12.2021, Time: 11:00 AM, Venue: Digital Platform. Record Date: 18.11.2021. The Company has also reported EPS of Tk. 4.03, NAV per share of Tk. 122.70 and NOCFPS of Tk. 8.38 for the year ended on June 30, 2021 as against Tk. 4.35, Tk. 121.66 and Tk. (1.48) respectively for the same period of the previous year.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (28.10.2021) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2021 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.77 for January-March 2021 as against Tk. 1.04 for January-March 2020; EPS was Tk. 3.65 for July 2020-March 2021 as against Tk. 3.63 for July 2019-March 2020. NOCFPS was Tk. 3.70 for July 2020-March 2021 as against Tk. (6.76) for July 2019-March 2020. NAV per share was Tk. 122.32 as on March 31, 2021 and Tk. 121.66 as on June 30, 2020.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2020 to the respective shareholders.
- (Q2 Un-audited): EPS was Tk. 2.08 for October-December 2020 as against Tk. 1.36 for October-December 2019; EPS was Tk. 2
(Q2 Un-audited): EPS was Tk. 2.08 for October-December 2020 as against Tk. 1.36 for October-December 2019; EPS was Tk. 2.88 for July-December 2020 as against Tk. 2.59 for July-December 2019. NOCFPS was Tk. 2.20 for July-December 2020 as against Tk. (6.72) for July-December 2019. NAV per share was Tk. 121.55 as on December 31, 2020 and Tk. 121.66 as on June 30, 2020.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.